All issues

The paper proposes a mathematical model for the therapy of glioma, taking into account the blood-brain barrier, radiotherapy and antibody therapy. The parameters were estimated from experimental data and the evaluation of the effect of parameter values on the effectiveness of treatment and the prognosis of the disease were obtained. The possible variants of sequential use of radiotherapy and the effect of antibodies have been explored. The combined use of radiotherapy with intravenous administration of $mab$ $Cx43$ leads to a potentiation of the therapeutic effect in glioma.

Radiotherapy must precede chemotherapy, as radio exposure reduces the barrier function of endothelial cells. Endothelial cells of the brain vessels fit tightly to each other. Between their walls are formed so-called tight contacts, whose role in the provision of BBB is that they prevent the penetration into the brain tissue of various undesirable substances from the bloodstream. Dense contacts between endothelial cells block the intercellular passive transport.

The mathematical model consists of a continuous part and a discrete one. Experimental data on the volume of glioma show the following interesting dynamics: after cessation of radio exposure, tumor growth does not resume immediately, but there is some time interval during which glioma does not grow. Glioma cells are divided into two groups. The first group is living cells that divide as fast as possible. The second group is cells affected by radiation. As a measure of the health of the blood-brain barrier system, the ratios of the number of BBB cells at the current moment to the number of cells at rest, that is, on average healthy state, are chosen.

The continuous part of the model includes a description of the division of both types of glioma cells, the recovery of BBB cells, and the dynamics of the drug. Reducing the number of well-functioning BBB cells facilitates the penetration of the drug to brain cells, that is, enhances the action of the drug. At the same time, the rate of division of glioma cells does not increase, since it is limited not by the deficiency of nutrients available to cells, but by the internal mechanisms of the cell. The discrete part of the mathematical model includes the operator of radio interaction, which is applied to the indicator of BBB and to glial cells.

Within the framework of the mathematical model of treatment of a cancer tumor (glioma), the problem of optimal control with phase constraints is solved. The patient’s condition is described by two variables: the volume of the tumor and the condition of the BBB. The phase constraints delineate a certain area in the space of these indicators, which we call the survival area. Our task is to find such treatment strategies that minimize the time of treatment, maximize the patient’s rest time, and at the same time allow state indicators not to exceed the permitted limits. Since the task of survival is to maximize the patient’s lifespan, it is precisely such treatment strategies that return the indicators to their original position (and we see periodic trajectories on the graphs). Periodic trajectories indicate that the deadly disease is translated into a chronic one.

Inhibitors of histone deacetylases (HDACi) have considered as a promising class of drugs for the treatment of cancers because of their effects on cell growth, differentiation, and apoptosis. Angiogenesis play an important role in the growth of most solid tumors and the progression of metastasis. The vascular endothelial growth factor (VEGF) is a key angiogenic agent, which is secreted by malignant tumors, which induces the proliferation and the migration of vascular endothelial cells. Currently, the most promising strategy in the fight against cancer is the creation of hybrid drugs that simultaneously act on several physiological targets. In this work, a series of hybrids bearing N-phenylquinazolin-4-amine and hydroxamic acid moieties were studied as dual VEGFR-2/HDAC inhibitors using simplex representation of the molecular structure and Support Vector Machine (SVM). The total sample of 42 compounds was divided into training and test sets. Five-fold cross-validation (5-fold) was used for internal validation. Satisfactory quantitative structure—activity relationship (QSAR) models were constructed (R²_test = 0.64–0.87) for inhibitors of HDAC, VEGFR-2 and human breast cancer cell line MCF-7. The interpretation of the obtained QSAR models was carried out. The coordinated effect of different molecular fragments on the increase of antitumor activity of the studied compounds was estimated. Among the substituents of the N-phenyl fragment, the positive contribution of para bromine for all three types of activity can be distinguished. The results of the interpretation were used for molecular design of potential dual VEGFR-2/HDAC inhibitors. For comparative QSAR research we used physicochemical descriptors calculated by the program HYBOT, the method of Random Forest (RF), and on-line version of the expert system OCHEM (https://ochem.eu). In the modeling of OCHEM PyDescriptor descriptors and extreme gradient boosting was chosen. In addition, the models obtained with the help of the expert system OCHEM were used for virtual screening of 300 compounds to select promising VEGFR-2/HDAC inhibitors for further synthesis and testing.

In the last decade along with classical cytotoxic agents, antiangiogenic drugs have been actively used in cancer chemotherapy. They are not aimed at killing malignant cells, but at blocking the process of angiogenesis, i.e., the growth of new vessels in the tumor and its surrounding tissues. Agents that stimulate angiogenesis, in particular, vascular endothelial growth factor, are actively produced by tumor cells in the state of metabolic stress. It is believed that blocking of tumor neovascularization should lead to a shortage of nutrients flow to the tumor, and thus can stop, or at least significantly slow down its growth. Clinical practice on the use of first antiangiogenic drug bevacizumab has shown that in some cases such therapy does not influence the growth rate of the tumor, whereas for other types of malignant neoplasms antiangiogenic therapy has a high antitumor effect. However, it has been shown that along with successful slowing of tumor growth, therapy with bevacizumab can induce directed tumor progression to a more invasive, and therefore more lethal, type. These data require theoretical analysis and rationale for the evolutionary factors that lead to the observation of epithelial-mesenchymal transition. For this purpose we have developed a spatially distributed mathematical model of growth and antiangiogenic therapy of heterogeneous tumor consisting of two subpopulations of malignant cells. One of subpopulations possesses inherent characteristics of epithelial phenotype, i.e., low motility and high proliferation rate, the other one corresponds to mesenchymal phenotype having high motility and low proliferation rate. We have performed the investigation of competition between these subpopulations of heterogeneous tumor in the cases of tumor growth without therapy and under bevacizumab monotherapy. It is shown that constant use of antiangiogenic drug leads to an increase of the region in parameter space, where the dominance of mesenchymal phenotype takes place, i.e., within a certain range of parameters in the absence of therapy epithelial phenotype is dominant but during bevacizumab administration mesenchymal phenotype begins to dominate. This result provides a theoretical basis of the clinically observed directed tumor progression to more invasive type under antiangiogenic therapy.

In this paper we propose a mathematical model of cancer tumour occurrence in a quasi twodimensional epithelial tissue. Basic model of the epithelium growth describes the appearance of intensive movement and growth of tissue when it is damaged. The model includes the effects of division of cells and intercalation. It is assumed that the movement of cells is caused by the wave of mitogen-activated protein kinase (MAPK), which in turn activated by the chemo-mechanical signal propagating along tissue due to its local damage. In this paper it is assumed that cancer cells arise from local failure of spatial synchronization of circadian rhythms. The study of the evolutionary dynamics of the model could determine the chemo-physical properties of a tumour, and spatial relationship between the occurrence of cancer cells and development of the entire tissue parameters coordinating its evolution through the exchange of chemical and mechanical signals.

In this paper, we proposed a two-dimensional chemo-mechanical model of the growth of invasive carcinoma in epithelial tissue. Each cell is modeled by an elastic polygon, changing its shape and size under the influence of pressure forces acting from the tissue. The average size and shape of the cells have been calibrated on the basis of experimental data. The model allows to describe the dynamic deformations in epithelial tissue as a collective evolution of cells interacting through the exchange of mechanical and chemical signals. The general direction of tumor growth is controlled by a pre-established linear gradient of nutrient concentration. Growth and deformation of the tissue occurs due to the mechanisms of cell division and intercalation. We assume that carcinoma has a heterogeneous structure made up of cells of different phenotypes that perform various functions in the tumor. The main parameter that determines the phenotype of a cell is the degree of its adhesion to the adjacent cells. Three main phenotypes of cancer cells are distinguished: the epithelial (E) phenotype is represented by internal tumor cells, the mesenchymal (M) phenotype is represented by single cells and the intermediate phenotype is represented by the frontal tumor cells. We assume also that the phenotype of each cell under certain conditions can change dynamically due to epithelial-mesenchymal (EM) and inverse (ME) transitions. As for normal cells, we define the main E-phenotype, which is represented by ordinary cells with strong adhesion to each other. In addition, the normal cells that are adjacent to the tumor undergo a forced EM-transition and form an M-phenotype of healthy cells. Numerical simulations have shown that, depending on the values of the control parameters as well as a combination of possible phenotypes of healthy and cancer cells, the evolution of the tumor can result in a variety of cancer structures reflecting the self-organization of tumor cells of different phenotypes. We compare the structures obtained numerically with the morphological structures revealed in clinical studies of breast carcinoma: trabecular, solid, tubular, alveolar and discrete tumor structures with ameboid migration. The possible scenario of morphogenesis for each structure is discussed. We describe also the metastatic process during which a single cancer cell of ameboid phenotype moves due to intercalation in healthy epithelial tissue, then divides and undergoes a ME transition with the appearance of a secondary tumor.

Chemotaxis plays an important role in morphogenesis and processes of structure formation in nature. Both unicellular organisms and single cells in tissue demonstrate this property. In vitro experiments show that many types of transformed cell, especially metastatic competent, are capable for directed motion in response usually to chemical signal. There is a number of theoretical papers on mathematical modeling of tumour growth and invasion using Keller-Segel model for the chemotactic motility of cancer cells. One of the crucial questions for using the chemotactic term in modelling of tumour growth is a lack of reliable quantitative estimation of its parameters. The 2-D mathematical model of tumour growth and invasion, which takes into account only random cell motility and convective fluxes in compact tissue, has showed that due to competitive mechanism tumour can grow toward sources of nutrients in absence of chemotactic cell motility.

This paper is devoted to the analysis of the partial mathematical model describing the process of growth and spread of malignant and normal cells under the influence of chemotherapy. We found the periodic therapy regime, conditions the existence of this regime and suggest the search algorithm of this regime. This paper also includes the examples of simulation and the set of parameter values.